DUBLIN–(BUSINESS WIRE)–The “Compounding Pharmacies Market By Therapeutic Area, By Route of Administration, By Sterility: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.
According to this report the compounding pharmacies market was valued at $8.12 billion in 2021, and is estimated to reach $14.84 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031.
Compounding is preparation of a custom formulation of a medication to fit a unique need of a patient that cannot be met with commercially available products. They are able to make unique medications for each person as some people need drugs that are not available on the market. Compounding pharmacies can be of assistance in this situation since there are several potential causes for this need.
Compounding pharmacies can create sterile and non-sterile chemicals. While some pharmacies may provide services for both types of compounding, others may only specialize in one. Injections, ocular drops, and infusions are examples of dosage forms that contain sterile substances.
The major factors that drive the growth of the global compound pharmacies market include increase in prevalence of chronic disease, high adoption of non-sterile medication, increase in old age population and improved life expectancy. In addition, growing drug failure rate, increase in popularity of personalized medicine and massive drug shortage across the globe is further propel the market growth during forecast period.
However, increase in restrictions on manufacturing of complex formulation is likely to restrain the growth of the compounding pharmacies market during the forecast period. Conversely, growth potential of emerging economies is anticipated to provide numerous opportunities for market growth during the forecast period.
Key Benefits
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the compounding pharmacies market analysis from 2021 to 2031 to identify the prevailing compounding pharmacies market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the compounding pharmacies market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global compounding pharmacies market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Therapeutic Area
- Pain Management
- Hormone Replacement Therapy
- Dermal Disorders
- Nutritional Supplements
- Others
By Route of Administration
- Oral
- Topical
- Others
By Sterility
- Non-Sterile Compounding Drugs
- Distribution Channel
- Hospital Pharmacy
- Compounding Pharmacy
- Others
- Sterile Compounding Drugs
- Distribution Channel
- Hospital Pharmacy
- Compounding Pharmacy
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Italy
- Spain
- Rest of Europe
- Germany
- France
- UK
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Advanced Pharmacy
- Athenex Pharma Solutions
- B. Braun Melsungen AG
- Dougherty’s Pharmacy, Inc.
- Fresenius SE and Co. KGaA
- Institutional pharmacy solutions
- ITC compounding pharmacy
- McGuff Companies, Inc.
- Nephron pharmaceuticals
- New Compounding Pharma
- Olympia Compounding Pharmacy
- Panacea Biomatx Inc (Triangle Compounding Pharmacy)
- Pencol compounding pharmacy
- Perrigo Company Plc (Fagron)
- Rx express compounding pharmacy
- RX3 compounding pharmacy
- Valor Compounding Pharmacy
For more information about this report visit https://www.researchandmarkets.com/r/wsvpke
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
